Clinical Trial Update: Tc99m-MAA Bronchial Artery Injection During Bronchial Embolization for Pulmonary Mass Induced Hemoptysis for Dosimetry Planning [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating Tc99m-MAA injected into the bronchial artery during bronchial embolization to assist dosimetry planning for pulmonary masses c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Drugs mentioned

• Tc99m-MAA (technetium-99m macroaggregated albumin)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Lung Cancer | Phase 1 | Status: COMPLETED